By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Massachusetts Biologic Laboratories 

55 Lake Avenue

North Worcester  Massachusetts  01655  U.S.A.
Phone: 508-856-2000 Fax:


SEARCH JOBS








Company News
Novel Antibody Prevents Infection By Hepatitis C Virus, Massachusetts Biologic Laboratories Study 5/5/2009 11:56:39 AM
Merck & Co., Inc. (MRK) Signs Licensing Deal; Medarex, Inc. (MEDX) and Massachusetts Biologic Laboratories to Get Payments up to $165 Million 4/21/2009 7:14:52 AM
Medarex, Inc. (MEDX) and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea 11/3/2008 9:33:15 AM
Akorn, Inc. (AKN) Signs Exclusive Distribution Agreement With Massachusetts Biologic Laboratories For Tetanus Diphtheria Vaccine 3/27/2007 1:20:30 PM
Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories Announce Commencement Of Phase II Clinical Trial Of Anti-C. difficile Antibody Combination For The Treatment Of Hospital Acquired Diarrhea 9/6/2006 10:56:18 AM
Sinovac Biotech Ltd. (SNVBF) To Test Fully Human Antibody Developed By Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories For Its Ability To Neutralize The SARS Virus 10/19/2005 5:11:03 PM
Medarex, Inc. (MEDX) And Massachusetts Biologic Laboratories Release: SARS Antibody Sent To China For Preclinical Testing 10/19/2005 5:11:03 PM
Massachusetts Biologic Laboratories And Medarex, Inc. (MEDX) Announce Phase I Clinical Trial Of A Novel Fully Human Antibody For The Treatment Of Hospital Acquired Diarrhea 10/19/2005 5:09:13 PM
//-->